Skip to main content

I liver pawh hi thauin a khat em? Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) chungchang hi han sawi ila.

I liver pawh hi thauin a khat em? Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) chungchang hi han sawi ila.

I taksa rihna sang zawk i phurh emaw, zunthlum ang chi i neih emaw hian i liver pawh a nghawng thei tih i ngaihtuah ngai em? A châng chuan, hriat lohvin kan liver-ah thau kan khawlkhawm ṭan ṭhin. Chu chu vawiin a kan sawi tur condition pakhat a ni a, chu chu MASLD an ti a ni. Lungngai suh, hei hi awlsam takin i hrethiam ang u.

He MASLD hi eng nge ni?

A awlsam zawngin sawi ila, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) hi i thin cell chhunga thau tam lutuk avanga lo awm a ni. Steatotic (fatty) liver disease (SLD) an ti bawk. Tun hma chuan NAFLD (Nonalcoholic Fatty Liver Disease) tia koh a ni a, chu chu zu in vangin *nilo* vangin liver-ah thau a pung khawm tihna a ni. Mahse tunah chuan he hming hi MASLD tia thlak a ni ta a, a chhan chu kan taksa metabolism-a thil danglam thenkhat nen a inzawm tlat tih hmuhchhuah a ni.

Kan in chhunga bawlhhlawh a khawlkhawm ang bawkin, liver-a thau a punkhawm hian hun kal zelah hepatitis a thlen thei a, chu chu thin inflammation a ni. Hetiang dinhmun hi khawvela chronic liver diseases zingah chuan a langsar ber pawl a ni. A bik takin thau lutuk leh type 2 diabetes nei zingah a hluar hle. Heng dinhmunte hi a pun chhoh zel chuan khawvel mihring 30% aia tam chuan MASLD an vei thei niin mithiamte chuan an chhut. MASLD hi enkawl loh chuan thin natna khirh zawk a thlen thei a ni. Chuvangin, a hmaa hriatchhuah leh enkawl a nih chuan he natna hi a zual zel loh nan a veng thei a ni.

MASLD natna lan chhuah dante chu engte nge ni?

Vawi tam tak chu he MASLD an tih hi kum tam tak chhung chu a tir lamah chuan a lan chhuah lohvin a lo awm thei thin. Chumi awmzia chu natna chu i taksa chhungah danglamna i hriat lohvin a awm thei tihna a ni. Buaina, inthup taka lo thang lian tak angin ngaihtuah rawh.

Mahse, he natna hi MASH (Metabolic Dysfunction-Associated Steatohepatitis) tih hming pu stage na zawk a thlen chuan symptom thenkhat a lang tan thin. MASH hi liver-a thau a punkhawm a, inflammation ruala liver a tihchhiat tan hian a ni. Hei hian liver fibrosis, scar tissue siamna, cirrhosis ang chi dinhmun a thlen thei a ni. Chutiang a nih chuan symptoms i nei thei a, chungte chu:

  • I pum dinglam chunglam, i liver awmna hmunah hian natna emaw, nuam lo emaw engemaw zat i nei a ni .
  • Ngaihtuah phak loh khawpa chau leh nunna nei lo anga inhriatna.
  • Chaw chu a thlum lo.
  • I pum a hring ang maia inhriatna.
  • Chhan awm lova thinrim .
  • I vun leh i mit var chu a sen (jaundice ang bawkin doctor te pawhin hei hi scleral icterus an ti bawk ).

Heng symptoms pakhat emaw a aia tam emaw i neih chuan doctor thurawn lak a pawimawh.

MASLD hi engte nge ni?

MASLD vei chhan ber chu i taksa metabolic process-a thil danglam thenkhat a awm vang a ni. He metabolism hi kan ei tur chu chakna ah a chantir dan a ni. Hetiang kalphungah hian harsatna a awm chuan MASLD a awm thei. Hei hi a nghawngtu thil pawimawh thenkhat chu hetiang hi a ni:

  • Dyslipidemia: Hei hi i thisena thau, a bik takin cholesterol ang chi lipids level chu a tlangpui aia a san chuan a ni .
  • Thau lutuk: I Body Mass Index (BMI) 30 aia sang a nih chuan thau lutuk anga ngaih i ni. Mi thau tam lutuk, a bik takin pum chhehvela awmte chu MASLD vei theihna a sang zawk.
  • Insulin resistance: Insulin hi kan thisena sugar (glucose) level control tu hormone a ni. Insulin resistance tih awmzia chu i taksa ruh, thau cell leh thin cell te hian insulin an dawng tha lo tihna a ni. Hei hian thisen sugar level control a ti harsa hle.
  • Type 2 diabetes: Hei pawh hi hun rei tak chhunga natna a ni. Heta thil thleng hi thisen sugar level a sang reng (hyperglycemia).

Heng bakah hian zirchiannaah chuan genetic variation thenkhat chuan MASLD vei theihna a tipung thei bawk tih hmuhchhuah a ni.

MASLD avanga harsatna awm thei te chu engte nge ni?

MASLD vei thenkhatin MASH tih hming pu condition an neih theih dan tur kan sawi tawh a. He MASH condition hi a na zual a nih chuan a hnuaia harsatna te hi a lo awm thei a ni:

  • MASH with liver fibrosis: Fibrosis tih hi liver chhunga scar tissue siam a ni. He scarring hi liver cells te a chhiat a, mahni insiamthat tumna atanga lo awm a ni.
  • MASH-related cirrhosis: Cirrhosis hi thin (liver) a chhiat nasat avangin a hnathawh theihna a hloh thin a ni. Hei hi a pawi hle a, nunna atana hlauhawm tak a ni thei bawk.
  • Liver cancer (Hepatocellular carcinoma): Hei hi liver cancer chi khat a ni a, MASH avanga lo awm thei a ni.

MASLD hian heng thin (liver-related problems) te hi a thlen mai bakah natna khirh tak dang a thlen theihna a tipung thei bawk. Entir nan:

  • Cancer: Cancer chi hrang hrang, hnute cancer leh colorectal cancer te.
  • Cardiovascular disease: Thinlung leh thisen kalna kawng nena inzawm natna.
  • Zunthlum: Tuna zunthlum vei lote chuan zunthlum thar an nei thei a.

Engtin nge MASLD hi hmuhchhuah a nih?

MASLD i vei em tih chiang taka hriat theih nan doctor-te chuan thisen test leh imaging test eng emaw zat an nei tlangpui. A châng chuan, test nan (liver biopsy) an liver hmun tlemte an lak a ngai thei bawk.

Thisen test a ni

Doctor chuan thisen test eng emaw zat a ti thei a, chungte chu:

  • A1C test: Hei hian thla hnih atanga thla thum kalta chhunga i thisen sugar level average a teh thin.
  • Complete Blood Count (CBC): Hei hian i thisena cell chi hrang hrang awm zat leh a nihna a enfiah thin.
  • Comprehensive Metabolic Panel (CMP): Hei hian i thisena thil 14 vel, protein leh electrolyte te level a test thin.
  • Lipid panel: Hei hi rilru lam natna test a ni. I thisena thau chi hrang hrang (cholesterol, triglycerides) awm zat a teh thin.
  • Liver function tests: Heng thisen test te hian liver atanga thil chi hrang hrang (enzyme, proteins) siam te chu a teh a, chu chuan liver hriselna chungchang a ngaihtuah thei a ni.

Imaging test te pawh a awm

I doctor chuan i liver-a MASLD chhinchhiahna awm leh awm loh enfiah nan hetiang scan hi a ti thei ang:

  • FibroScan®: He scan hian i liver-a thau awm zat leh fibrosis awm zat hriat theihna a pe thei a ni.
  • Magnetic Resonance Elastography leh Proton Density Fat Fraction (MRE-PDFF): Hei hi scan chi khat bik a ni bawk. Liver-a thau percentage leh fibrosis degree te chu dik takin a teh thei a ni.

Biopsy tih a ni

A tlem hle a, i doctor-in i natna lan chhuah dan hi MASLD tih loh thil dang avanga lo awm nia a rinhlelh a nih chuan, emaw, fibroscan ang chi test hnua thu belhchian dawl zawk an mamawh a nih chuan, i liver atanga tissue te tak te (liver biopsy) la chhuakin microscope hmangin an enfiah thei a ni.

MASLD hi engtin nge enkawl a nih?

MASLD enkawl hian a hmasa berah chuan taksa rihna tihtlem hi a ni . Chu bakah, MASLD thlentu dinhmun bulpui, zunthlum, cholesterol sang, leh thisen sang te pawh enkawl a ni bawk.

Dik tak chuan, taksa rihna tihtlem hian i liver hriselnaah danglamna nasa tak a thlen thei a ni. Liver-a thau tam lutuk tihtlem hian cirrhosis ang chi natna thlen thei inflammation control nan a pui thei a ni. I doctor chuan special diet plan, Mediterranean diet emaw DASH diet emaw a rawt thei ang. Heng diet te hi article hranpaah kan sawi dawn a ni.

Ni khatah minute 30 tal exercise tlemte, kar khatah ni thum chhung exercise neih hian i taksa rihna a ti tlem thei a ni. I doctor chuan i taksa rih zawng zawng zawng 10% emaw a aia tam emaw tihtlem turin a hrilh thei che a ni. Mahse, i taksa rih zawng 3% atanga 5% tihtlem pawhin danglamna nasa tak a thlen thei .

I taksa rihna tihtlem nan damdawi

Zunthlum leh/ emaw thau lutuk i neih chuan i doctor chuan i taksa rihna tihtlem nan damdawi, GLP-1 agonists te chu a pe thei che a ni. Heng damdawi te hian i thisen sugar level a tihniam a, i taksa rihna tihtlem nan a pui bawk. Entirna thenkhat chu:

  • Semaglutide (Ozempic® emaw Wegovy® emaw) hmanga siam a ni.
  • Liraglutide (Liraglutide - Victoza® emaw Saxenda® emaw) tih hi a tha hle.
  • Tirzepatide (Mounjaro® emaw Zepbound® emaw) hman a ni.

Bariatric surgery tih a ni

A châng chuan i doctor pawhin bariatric surgery chungchang a sawipui thei bawk. Cirrhosis a lo awm hmaa MASLD i vei tih hmuhchhuah a nih chuan he i taksa rihna tihtlem surgery hian i dinhmun a tidanglam thei a ni.

MASLD dinhmun hi tihdanglam theih a ni em?

Ni e, tih theih a ni! Mahse i dinhmunah a innghat. A tlangpuiin MASH nena inzawm cirrhosis i neih loh chuan enkawlna hian MASLD a tidanglam thei a ni.

He natna hi hriat hmasak a pawimawh . Hei hian liver chhiatna chu a na lutuk hmain a thunun thei a ni. I taksa rihna tihtlem leh nunphung tihdanglam hian MASLD avanga liver chhiatna chu a tidanglam thei a ni. Mahse, hei hi i hriselna zawng zawngah a innghat a ni. Chuvangin, i taksa rihna tihtlem hian i dinhmun a tidanglam thei em tih doctor zawt rawh.

MASLD hi ven theih a ni em?

Hetiang dinhmun hian thau lutuk leh type 2 diabetes nei te a nghawng fo thin. Heng dinhmunte hi a lo awm loh nan a khap tlat theih loh mai thei. Mahse, a hmaa hriatchhuah leh nunphung thlak danglam hian MASLD lo awm tur venna emaw, thunun emaw a pui thei a ni.

I thau lutuk emaw, type 2 diabetes i neih chuan i doctor chuan thisen test leh scan hmanga i natna chhinchhiahna enfiah turin a rawt thei ang. A hmaa man a nih chuan i risk tihziaawmna turin nunphung i thlak thei a ni.

MASLD nen hian eng chen nge i dam theih ang?

Research atanga a lan dan chuan MASLD neih hian i dam chhung a nghawng thei a ni. Entirnan, zirchianna pakhatah chuan MASLD vei te chu he natna nei lo te aiin a vaiin kum 2.8 velin an dam tlem zawk thei tih hmuhchhuah a ni.

Mahse, thil tam takin MASLD i dam rei tur chu a nghawng a ni. I dinhmun chu mi dangte nên a danglam thei a. Chuvangin, i doctor hi i beisei theih dan tur hriatna tha ber a ni.

Engtin nge ka in enkawl ang?

MASLD i vei a nih chuan i in enkawl dan tha ber chu doctor-te nen thawhhona tha tak neiin MASLD thlentu dinhmun, thau lutuk, thau lutuk, leh type 2 diabetes te control hi a ni. I taksa rihna tihtlem leh active taka awm hian liver chhiatna a tihziaawm thei a, a tidanglam thei bawk.Thurawn dang thenkhat chu hetiang hi a ni:

  • I hriselna zawng zawng hi fimkhur rawh. MASLD hian zunthlum, thinlung natna leh cancer chi thenkhat i vei theihna a tipung a ni. Chuvangin, i risk tihtlem nan eng test nge i tih theih tih i chhungkaw doctor zawt rawh.
  • I liver tana tha tur tih dan siam rawh. Meizial zu leh zu in bansan rawh. Meizial leh zu hian i liver-ah stress a siam belh zel a ni. Tin, hepatitis A leh hepatitis B laka vaccine lak dan tur i doctor zawt bawk ang che.
  • Beidawng suh, bei zel rawh.

Thau tihtlem nan hian hun a duh a ni. Inthlauhna lian tak i hmu nghal lo mai thei, mahse zawi zawiin result i hmu ang. Tin, exercise neih fo hi inpekna a ni bawk. He zinkawngah hian i chau emaw, i bo emaw i tih chuan i doctor nen sawiho rawh.

Engtikah nge Doctor ka hmuh ang?

I taksaa inthlak danglamna i hmuh chuan, a hma aia chau zawka i hriat emaw, i pum dinglam sir lam natna emaw i neih chuan doctor hmu ngei ang che . Heng inthlak danglamna te hian MASH natna khirh tak a nih thu a tilang thei a, hei hi fatty liver disease a ni a, chu chu cirrhosis leh hepatocellular cancer ang chi natna khirh zawkah a kal thei a ni.

Zu in hian MASLD a thlen em?

Ni lo, zu in hian direct-in MASLD a thlen lo. Kan sawi tawh ang khan hei hi a hmain non-alcoholic fatty liver disease (NAFLD) an ti a. Chumi awmzia chu zu in tam loh pawhin he natna hi a lo awm thei tihna a ni.

Mahse, a pawimawh ber chu MASLD vei hian zu a in a nih chuan mi pangngai aiin cirrhosis vei theihna a sang zawk hle. Chuvangin doctor-te chuan MASLD vei te chu zu in loh vek turin an fuih tlangpui.

A tawp berah chuan thil hriat reng tur

Kum tin physical i neih laiin thisen test-naah i liver-ah harsatna i nei tih a hriat chuan MASLD i vei tih finfiah nan test dang neih belh theih a ni. He thin natna hi uluk taka enkawl loh chuan harsatna lian zawk a thlen thei a ni.

Mahse thu lawmawm tak chu nunphung inthlak danglamna, taksa rihna tihtlem leh active taka awm te hian MASLD a na zual loh nan a pui thei a ni. I liver chhiatna pawh an tidanglam thei bawk. Mahse, taksa rihna tihtlem leh active taka awm hi zan khat thil thua tih theih a ni lo. Hun leh inpekna a ngai a ni. Ni engemaw zat chu heng thilte hi i chau tawh ang maiin i inhria mai thei. I healthcare team chuan thil hlawhtling lo ang maia tih tum chu harsatna chu an hrethiam a ni. Chuvangin, tanpuina leh thlawpna dil hreh ngai suh. I liver hi i tan a hlu a, i enkawl tur chu nangmah thu a ni!


` Liver thau, thin thau, zunthlum, thau lutuk, cirrhosis, thin hriselna

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Comment a la awm lo. Hetah hian i comment hi a vawikhatna atan add rawh.

I comment kha add rawh

Khawngaihin chhut la: 3 + 5 =
I liver pawh hi thauin a khat em? Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) chungchang hi han sawi ila.

I liver pawh hi thauin a khat em? Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) chungchang hi han sawi ila.

I taksa rihna sang zawk i phurh emaw, zunthlum ang chi i neih emaw hian i liver pawh a nghawng thei tih i ngaihtuah ngai em? A châng chuan, hriat lohvin kan liver-ah thau kan khawlkhawm ṭan ṭhin. Chu chu vawiin a kan sawi tur condition pakhat a ni a, chu chu MASLD an ti a ni. Lungngai suh, hei hi awlsam takin i hrethiam ang u.

He MASLD hi eng nge ni?

A awlsam zawngin sawi ila, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) hi i thin cell chhunga thau tam lutuk avanga lo awm a ni. Steatotic (fatty) liver disease (SLD) an ti bawk. Tun hma chuan NAFLD (Nonalcoholic Fatty Liver Disease) tia koh a ni a, chu chu zu in vangin *nilo* vangin liver-ah thau a pung khawm tihna a ni. Mahse tunah chuan he hming hi MASLD tia thlak a ni ta a, a chhan chu kan taksa metabolism-a thil danglam thenkhat nen a inzawm tlat tih hmuhchhuah a ni.

Kan in chhunga bawlhhlawh a khawlkhawm ang bawkin, liver-a thau a punkhawm hian hun kal zelah hepatitis a thlen thei a, chu chu thin inflammation a ni. Hetiang dinhmun hi khawvela chronic liver diseases zingah chuan a langsar ber pawl a ni. A bik takin thau lutuk leh type 2 diabetes nei zingah a hluar hle. Heng dinhmunte hi a pun chhoh zel chuan khawvel mihring 30% aia tam chuan MASLD an vei thei niin mithiamte chuan an chhut. MASLD hi enkawl loh chuan thin natna khirh zawk a thlen thei a ni. Chuvangin, a hmaa hriatchhuah leh enkawl a nih chuan he natna hi a zual zel loh nan a veng thei a ni.

MASLD natna lan chhuah dante chu engte nge ni?

Vawi tam tak chu he MASLD an tih hi kum tam tak chhung chu a tir lamah chuan a lan chhuah lohvin a lo awm thei thin. Chumi awmzia chu natna chu i taksa chhungah danglamna i hriat lohvin a awm thei tihna a ni. Buaina, inthup taka lo thang lian tak angin ngaihtuah rawh.

Mahse, he natna hi MASH (Metabolic Dysfunction-Associated Steatohepatitis) tih hming pu stage na zawk a thlen chuan symptom thenkhat a lang tan thin. MASH hi liver-a thau a punkhawm a, inflammation ruala liver a tihchhiat tan hian a ni. Hei hian liver fibrosis, scar tissue siamna, cirrhosis ang chi dinhmun a thlen thei a ni. Chutiang a nih chuan symptoms i nei thei a, chungte chu:

  • I pum dinglam chunglam, i liver awmna hmunah hian natna emaw, nuam lo emaw engemaw zat i nei a ni .
  • Ngaihtuah phak loh khawpa chau leh nunna nei lo anga inhriatna.
  • Chaw chu a thlum lo.
  • I pum a hring ang maia inhriatna.
  • Chhan awm lova thinrim .
  • I vun leh i mit var chu a sen (jaundice ang bawkin doctor te pawhin hei hi scleral icterus an ti bawk ).

Heng symptoms pakhat emaw a aia tam emaw i neih chuan doctor thurawn lak a pawimawh.

MASLD hi engte nge ni?

MASLD vei chhan ber chu i taksa metabolic process-a thil danglam thenkhat a awm vang a ni. He metabolism hi kan ei tur chu chakna ah a chantir dan a ni. Hetiang kalphungah hian harsatna a awm chuan MASLD a awm thei. Hei hi a nghawngtu thil pawimawh thenkhat chu hetiang hi a ni:

  • Dyslipidemia: Hei hi i thisena thau, a bik takin cholesterol ang chi lipids level chu a tlangpui aia a san chuan a ni .
  • Thau lutuk: I Body Mass Index (BMI) 30 aia sang a nih chuan thau lutuk anga ngaih i ni. Mi thau tam lutuk, a bik takin pum chhehvela awmte chu MASLD vei theihna a sang zawk.
  • Insulin resistance: Insulin hi kan thisena sugar (glucose) level control tu hormone a ni. Insulin resistance tih awmzia chu i taksa ruh, thau cell leh thin cell te hian insulin an dawng tha lo tihna a ni. Hei hian thisen sugar level control a ti harsa hle.
  • Type 2 diabetes: Hei pawh hi hun rei tak chhunga natna a ni. Heta thil thleng hi thisen sugar level a sang reng (hyperglycemia).

Heng bakah hian zirchiannaah chuan genetic variation thenkhat chuan MASLD vei theihna a tipung thei bawk tih hmuhchhuah a ni.

MASLD avanga harsatna awm thei te chu engte nge ni?

MASLD vei thenkhatin MASH tih hming pu condition an neih theih dan tur kan sawi tawh a. He MASH condition hi a na zual a nih chuan a hnuaia harsatna te hi a lo awm thei a ni:

  • MASH with liver fibrosis: Fibrosis tih hi liver chhunga scar tissue siam a ni. He scarring hi liver cells te a chhiat a, mahni insiamthat tumna atanga lo awm a ni.
  • MASH-related cirrhosis: Cirrhosis hi thin (liver) a chhiat nasat avangin a hnathawh theihna a hloh thin a ni. Hei hi a pawi hle a, nunna atana hlauhawm tak a ni thei bawk.
  • Liver cancer (Hepatocellular carcinoma): Hei hi liver cancer chi khat a ni a, MASH avanga lo awm thei a ni.

MASLD hian heng thin (liver-related problems) te hi a thlen mai bakah natna khirh tak dang a thlen theihna a tipung thei bawk. Entir nan:

  • Cancer: Cancer chi hrang hrang, hnute cancer leh colorectal cancer te.
  • Cardiovascular disease: Thinlung leh thisen kalna kawng nena inzawm natna.
  • Zunthlum: Tuna zunthlum vei lote chuan zunthlum thar an nei thei a.

Engtin nge MASLD hi hmuhchhuah a nih?

MASLD i vei em tih chiang taka hriat theih nan doctor-te chuan thisen test leh imaging test eng emaw zat an nei tlangpui. A châng chuan, test nan (liver biopsy) an liver hmun tlemte an lak a ngai thei bawk.

Thisen test a ni

Doctor chuan thisen test eng emaw zat a ti thei a, chungte chu:

  • A1C test: Hei hian thla hnih atanga thla thum kalta chhunga i thisen sugar level average a teh thin.
  • Complete Blood Count (CBC): Hei hian i thisena cell chi hrang hrang awm zat leh a nihna a enfiah thin.
  • Comprehensive Metabolic Panel (CMP): Hei hian i thisena thil 14 vel, protein leh electrolyte te level a test thin.
  • Lipid panel: Hei hi rilru lam natna test a ni. I thisena thau chi hrang hrang (cholesterol, triglycerides) awm zat a teh thin.
  • Liver function tests: Heng thisen test te hian liver atanga thil chi hrang hrang (enzyme, proteins) siam te chu a teh a, chu chuan liver hriselna chungchang a ngaihtuah thei a ni.

Imaging test te pawh a awm

I doctor chuan i liver-a MASLD chhinchhiahna awm leh awm loh enfiah nan hetiang scan hi a ti thei ang:

  • FibroScan®: He scan hian i liver-a thau awm zat leh fibrosis awm zat hriat theihna a pe thei a ni.
  • Magnetic Resonance Elastography leh Proton Density Fat Fraction (MRE-PDFF): Hei hi scan chi khat bik a ni bawk. Liver-a thau percentage leh fibrosis degree te chu dik takin a teh thei a ni.

Biopsy tih a ni

A tlem hle a, i doctor-in i natna lan chhuah dan hi MASLD tih loh thil dang avanga lo awm nia a rinhlelh a nih chuan, emaw, fibroscan ang chi test hnua thu belhchian dawl zawk an mamawh a nih chuan, i liver atanga tissue te tak te (liver biopsy) la chhuakin microscope hmangin an enfiah thei a ni.

MASLD hi engtin nge enkawl a nih?

MASLD enkawl hian a hmasa berah chuan taksa rihna tihtlem hi a ni . Chu bakah, MASLD thlentu dinhmun bulpui, zunthlum, cholesterol sang, leh thisen sang te pawh enkawl a ni bawk.

Dik tak chuan, taksa rihna tihtlem hian i liver hriselnaah danglamna nasa tak a thlen thei a ni. Liver-a thau tam lutuk tihtlem hian cirrhosis ang chi natna thlen thei inflammation control nan a pui thei a ni. I doctor chuan special diet plan, Mediterranean diet emaw DASH diet emaw a rawt thei ang. Heng diet te hi article hranpaah kan sawi dawn a ni.

Ni khatah minute 30 tal exercise tlemte, kar khatah ni thum chhung exercise neih hian i taksa rihna a ti tlem thei a ni. I doctor chuan i taksa rih zawng zawng zawng 10% emaw a aia tam emaw tihtlem turin a hrilh thei che a ni. Mahse, i taksa rih zawng 3% atanga 5% tihtlem pawhin danglamna nasa tak a thlen thei .

I taksa rihna tihtlem nan damdawi

Zunthlum leh/ emaw thau lutuk i neih chuan i doctor chuan i taksa rihna tihtlem nan damdawi, GLP-1 agonists te chu a pe thei che a ni. Heng damdawi te hian i thisen sugar level a tihniam a, i taksa rihna tihtlem nan a pui bawk. Entirna thenkhat chu:

  • Semaglutide (Ozempic® emaw Wegovy® emaw) hmanga siam a ni.
  • Liraglutide (Liraglutide - Victoza® emaw Saxenda® emaw) tih hi a tha hle.
  • Tirzepatide (Mounjaro® emaw Zepbound® emaw) hman a ni.

Bariatric surgery tih a ni

A châng chuan i doctor pawhin bariatric surgery chungchang a sawipui thei bawk. Cirrhosis a lo awm hmaa MASLD i vei tih hmuhchhuah a nih chuan he i taksa rihna tihtlem surgery hian i dinhmun a tidanglam thei a ni.

MASLD dinhmun hi tihdanglam theih a ni em?

Ni e, tih theih a ni! Mahse i dinhmunah a innghat. A tlangpuiin MASH nena inzawm cirrhosis i neih loh chuan enkawlna hian MASLD a tidanglam thei a ni.

He natna hi hriat hmasak a pawimawh . Hei hian liver chhiatna chu a na lutuk hmain a thunun thei a ni. I taksa rihna tihtlem leh nunphung tihdanglam hian MASLD avanga liver chhiatna chu a tidanglam thei a ni. Mahse, hei hi i hriselna zawng zawngah a innghat a ni. Chuvangin, i taksa rihna tihtlem hian i dinhmun a tidanglam thei em tih doctor zawt rawh.

MASLD hi ven theih a ni em?

Hetiang dinhmun hian thau lutuk leh type 2 diabetes nei te a nghawng fo thin. Heng dinhmunte hi a lo awm loh nan a khap tlat theih loh mai thei. Mahse, a hmaa hriatchhuah leh nunphung thlak danglam hian MASLD lo awm tur venna emaw, thunun emaw a pui thei a ni.

I thau lutuk emaw, type 2 diabetes i neih chuan i doctor chuan thisen test leh scan hmanga i natna chhinchhiahna enfiah turin a rawt thei ang. A hmaa man a nih chuan i risk tihziaawmna turin nunphung i thlak thei a ni.

MASLD nen hian eng chen nge i dam theih ang?

Research atanga a lan dan chuan MASLD neih hian i dam chhung a nghawng thei a ni. Entirnan, zirchianna pakhatah chuan MASLD vei te chu he natna nei lo te aiin a vaiin kum 2.8 velin an dam tlem zawk thei tih hmuhchhuah a ni.

Mahse, thil tam takin MASLD i dam rei tur chu a nghawng a ni. I dinhmun chu mi dangte nên a danglam thei a. Chuvangin, i doctor hi i beisei theih dan tur hriatna tha ber a ni.

Engtin nge ka in enkawl ang?

MASLD i vei a nih chuan i in enkawl dan tha ber chu doctor-te nen thawhhona tha tak neiin MASLD thlentu dinhmun, thau lutuk, thau lutuk, leh type 2 diabetes te control hi a ni. I taksa rihna tihtlem leh active taka awm hian liver chhiatna a tihziaawm thei a, a tidanglam thei bawk.Thurawn dang thenkhat chu hetiang hi a ni:

  • I hriselna zawng zawng hi fimkhur rawh. MASLD hian zunthlum, thinlung natna leh cancer chi thenkhat i vei theihna a tipung a ni. Chuvangin, i risk tihtlem nan eng test nge i tih theih tih i chhungkaw doctor zawt rawh.
  • I liver tana tha tur tih dan siam rawh. Meizial zu leh zu in bansan rawh. Meizial leh zu hian i liver-ah stress a siam belh zel a ni. Tin, hepatitis A leh hepatitis B laka vaccine lak dan tur i doctor zawt bawk ang che.
  • Beidawng suh, bei zel rawh.

Thau tihtlem nan hian hun a duh a ni. Inthlauhna lian tak i hmu nghal lo mai thei, mahse zawi zawiin result i hmu ang. Tin, exercise neih fo hi inpekna a ni bawk. He zinkawngah hian i chau emaw, i bo emaw i tih chuan i doctor nen sawiho rawh.

Engtikah nge Doctor ka hmuh ang?

I taksaa inthlak danglamna i hmuh chuan, a hma aia chau zawka i hriat emaw, i pum dinglam sir lam natna emaw i neih chuan doctor hmu ngei ang che . Heng inthlak danglamna te hian MASH natna khirh tak a nih thu a tilang thei a, hei hi fatty liver disease a ni a, chu chu cirrhosis leh hepatocellular cancer ang chi natna khirh zawkah a kal thei a ni.

Zu in hian MASLD a thlen em?

Ni lo, zu in hian direct-in MASLD a thlen lo. Kan sawi tawh ang khan hei hi a hmain non-alcoholic fatty liver disease (NAFLD) an ti a. Chumi awmzia chu zu in tam loh pawhin he natna hi a lo awm thei tihna a ni.

Mahse, a pawimawh ber chu MASLD vei hian zu a in a nih chuan mi pangngai aiin cirrhosis vei theihna a sang zawk hle. Chuvangin doctor-te chuan MASLD vei te chu zu in loh vek turin an fuih tlangpui.

A tawp berah chuan thil hriat reng tur

Kum tin physical i neih laiin thisen test-naah i liver-ah harsatna i nei tih a hriat chuan MASLD i vei tih finfiah nan test dang neih belh theih a ni. He thin natna hi uluk taka enkawl loh chuan harsatna lian zawk a thlen thei a ni.

Mahse thu lawmawm tak chu nunphung inthlak danglamna, taksa rihna tihtlem leh active taka awm te hian MASLD a na zual loh nan a pui thei a ni. I liver chhiatna pawh an tidanglam thei bawk. Mahse, taksa rihna tihtlem leh active taka awm hi zan khat thil thua tih theih a ni lo. Hun leh inpekna a ngai a ni. Ni engemaw zat chu heng thilte hi i chau tawh ang maiin i inhria mai thei. I healthcare team chuan thil hlawhtling lo ang maia tih tum chu harsatna chu an hrethiam a ni. Chuvangin, tanpuina leh thlawpna dil hreh ngai suh. I liver hi i tan a hlu a, i enkawl tur chu nangmah thu a ni!


` Liver thau, thin thau, zunthlum, thau lutuk, cirrhosis, thin hriselna

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Comment a la awm lo. Hetah hian i comment hi a vawikhatna atan add rawh.

I comment kha add rawh

Khawngaihin chhut la: 3 + 5 =